[1]熊小平.通络益胃汤治疗慢性萎缩性胃炎的有效性及对复发率的影响[J].医学信息,2024,37(12):133-136.[doi:10.3969/j.issn.1006-1959.2024.12.030]
　XIONG Xiao-ping.Effect of Tongluo Yiwei Decoction in the Treatment of Chronic Atrophic Gastritis and its Effect on Recurrence Rate[J].Journal of Medical Information,2024,37(12):133-136.[doi:10.3969/j.issn.1006-1959.2024.12.030]
点击复制

通络益胃汤治疗慢性萎缩性胃炎的有效性及对复发率的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年12期
页码:
133-136
栏目:
论著
出版日期:
2024-06-15

文章信息/Info

Title:
Effect of Tongluo Yiwei Decoction in the Treatment of Chronic Atrophic Gastritis and its Effect on Recurrence Rate
文章编号:
1006-1959（2024）11-0133-04
作者:
熊小平
（樟树市第二人民医院消化内科，江西 樟树 331211）
Author(s):
XIONG Xiao-ping
(Department of Gastroenterology,Zhangshu Second People’s Hospital,Zhangshu 331211,Jiangxi,China)
关键词:
通络益胃汤; 慢性萎缩性胃炎; 胃痛; 嗳气; 复发率
Keywords:
Tongluo Yiwei decoction; Chronic atrophic gastritis; Stomachache; Belching; Recurrence rate
分类号:
R259
DOI:
10.3969/j.issn.1006-1959.2024.12.030
文献标志码:
A
摘要:
目的 分析通络益胃汤治疗慢性萎缩性胃炎的有效性及对复发率的影响。方法 选取2020年1月-2022年1月在我院诊治的66例慢性萎缩性胃炎患者为研究对象，采用随机数字表法分为对照组和观察组，各33例。对照组采用常规西药治疗，观察组在对照组基础上给予通络益胃汤治疗，比较两组临床疗效、中医证候（胃痛、嗳气、胃胀）评分、内镜病理积分、不良反应发生率及复发率。结果 观察组治疗总有效率（93.94%）高于对照组（84.85%）（P＜0.05）；两组治疗后胃痛、嗳气、胃胀评分均低于治疗前，且观察组低于对照组（P＜0.05）；两组治疗后内镜病理积分均低于治疗前，且观察组低于对照组（P＜0.05）；观察组不良反应发生率与对照组比较，差异无统计学意义（P＞0.05）；随访1个月，观察组复发率（9.09%）低于对照组（21.21%）（P＜0.05）。结论 通络益胃汤治疗慢性萎缩性胃炎具有较显著的有效性，可减轻中医证候，降低内镜病理积分和复发率，且不会增加不良反应，值得临床加以应用。
Abstract:
Objective To analyze the effect of Tongluo Yiwei decoction on the efficacy and recurrence rate of chronic atrophic gastritis.Methods A total of 66 patients with chronic atrophic gastritis diagnosed and treated in our hospital from January 2020 to January 2022 were selected as the research objects. They were divided into control group and observation group by random number table method, with 33 patients in each group. The control group was treated with conventional western medicine, and the observation group was treated with Tongluo Yiwei decoction on the basis of the control group. The clinical efficacy, TCM syndrome (stomach pain, belching, stomach distension) score, endoscopic pathological score, incidence of adverse reactions and recurrence rate were compared between the two groups.Results The total effective rate of treatment in the observation group (93.94%) was higher than that in the control group (84.85%) (P<0.05). After treatment, the scores of stomachache, belching and bloating in the two groups were lower than those before treatment, and those in the observation group were lower than those in the control group (P<0.05). After treatment, the endoscopic pathological score of the two groups was lower than that before treatment, and that of the observation group was lower than that of the control group (P<0.05). There was no significant difference in the incidence of adverse reactions between the observation group and the control group (P>0.05). After 1 month of follow-up, the recurrence rate of the observation group (9.09%) was lower than that of the control group (21.21%) (P<0.05).Conclusion Tongluo Yiwei decoction is effective in the treatment of chronic atrophic gastritis, which can reduce TCM syndromes, endoscopic pathological score and recurrence rate, and will not increase adverse reactions. It is worthy of clinical application.

参考文献/References:

[1]王文丽,要慧萍.耳穴贴压治疗腹腔镜术后胃肠功能障碍50例[J].西部中医药,2019,32(6):114-116.[2]孙希良,吕冠华,贾金玲,等.和胃止痛颗粒联合耳穴压豆治疗180例Hp感染慢性萎缩性胃炎的疗效观察[J].中国中西医结合消化杂志,2020,28(7):494-498.[3]中华医学会消化病学分会.中国慢性胃炎共识意见（2017年,上海）[J].中华消化杂志,2017,37(11):721-738.[4]中国中西医结合学会消化系统疾病专业委员会.慢性萎缩性胃炎中西医结合诊疗共识意见（2017年）[J].中国中西医结合消化杂志,2018,26(2):121-131.[5]马兴婷,张慧田,李合国.乌梅丸加减对寒热错杂型慢性浅表性胃炎患者PGⅠ、PGⅡ、GEDPRO-CG 的影响分析[J].中国中西医结合消化杂志,2019,27(2):106-110.[6]翟琦,陈英杰,宣佶,等.双歧杆菌三联活菌胶囊联合四联疗法对Hp阳性慢性浅表性胃炎炎症-氧化应激水平的影响[J].贵阳医学报,2020,45(2):209-213,218.[7]Xie WQ,Wang XF.MiR- 146a rs2910164 polymorphism increases the risk of digestive system cancer:A meta-analysis[J].Clin Res Hepatol Gastroenterol,2017,41(1):93-102.[8]李广宣.益胃健脾汤联合西药治疗脾胃虚弱型慢性萎缩性胃炎42例[J].中医研究,2019,32(4):39-41.[9]朱帅杰.综合康复治疗腰椎间盘突出症所致坐骨神经痛的临床疗效观察[J].实用医技杂志,2018,25(8):904-905.[10]朱亚楠.慢性萎缩性胃炎患者的中医证候与病理变化及幽门螺杆菌感染的相关性研究[J].现代中西医结合杂志,2018,27(36):4068-4071.[11]石芳,王志坤,刘启泉,等.基于中医传承辅助系统挖掘刘启泉治疗慢性萎缩性胃炎伴肠上皮化生用药规律[J].河南中医,2018,38(4):633-637.[12]徐明,陈睿,李颖,等.陈秀华综合疗法治疗慢性萎缩性胃炎经验探析[J].现代中西医结合杂志,2018,27(34):3803-3807.[13]李依洁,苏晓兰,史海霞,等.含枳术宽中胶囊的四联疗法治疗单纯幽门螺杆菌感染性胃炎的临床回顾性研究[J].实用药物与临床,2017,20(2):151-153.[14]曹元媛,徐春凤.中医经典名方治疗慢性萎缩性胃炎的研究[J].中药材,2022,45(4):1015-1018.[15]陈敏琴.针刺联合穴位贴敷治疗脾胃虚弱型慢性萎缩性胃炎疗效观察[J].基层医学论坛,2017,21(2):203-204.[16]李琪微.通络益胃汤治疗慢性萎缩性胃炎(胃络瘀血型)的临床研究[D].郑州:河南中医药大学,2018.[17]杨娜.针刺背俞穴治疗慢性萎缩性胃炎的临床观察及T淋巴细胞亚群的研究[D].咸阳:陕西中医药大学,2017[18]李天伦,李芳,邢艺子,等.黄芪建中汤对慢性萎缩性胃炎(脾胃虚弱证)患者胃镜指标和胃蛋白酶原变化的影响[J].吉林中医药,2023,20(4):177-180.[19]李艳,赵婷.标准四联联合荆花胃康胶丸对Hp阳性慢性萎缩性胃炎病人血清胃泌素17、PG及免疫功能的影响[J].蚌埠医学院学报,2023,15(2):65-68.[20]王艳玲,裴昆.健脾理气化瘀方治疗脾虚气滞型慢性萎缩性胃炎伴糜烂临床效果[J].深圳中西医结合杂志,2023,15(2):41-45.[21]刘永春,王政委.柴平养胃汤治疗慢性萎缩性胃炎48例疗效观察[J].中医临床研究,2022,20(7):150-153.

相似文献/References:

[1]陶 剑,奚美娟,张 平.益胃活血方治疗血瘀型慢性萎缩性胃炎临床观察[J].医学信息,2018,31(11):11.[doi:10.3969/j.issn.1006-1959.2018.11.004]
　TAO Jian,XI Mei-juan,ZHANG Ping.Clinical Observation on Yiwei Huoxue Recipe in Treating Chronic Atrophic Gastritis of Blood Stasis Type[J].Journal of Medical Information,2018,31(12):11.[doi:10.3969/j.issn.1006-1959.2018.11.004]
[2]张红新.益气清热活血方治疗慢性萎缩性胃炎及其 癌前期病变的临床研究[J].医学信息,2018,31(13):151.[doi:10.3969/j.issn.1006-1959.2018.13.046]
　ZHANG Hong-xin.Clinical Study of Yiqi Qingre Huoxue Decoction in Treating Chronic Atrophic Gastritis and Its Precancerous Lesions[J].Journal of Medical Information,2018,31(12):151.[doi:10.3969/j.issn.1006-1959.2018.13.046]
[3]张 皓.慢性萎缩性胃炎并发缺铁性贫血的危险因素分析[J].医学信息,2019,32(07):112.[doi:10.3969/j.issn.1006-1959.2019.07.033]
　ZHANG Hao.Logistic Regression Analysis of Risk Factors for Chronic Atrophic Gastritis Complicated with Iron Deficiency Anemia[J].Journal of Medical Information,2019,32(12):112.[doi:10.3969/j.issn.1006-1959.2019.07.033]
[4]梁丽丽,张 庆,戴 明.慢性萎缩性胃炎中医病机探讨[J].医学信息,2020,33(01):154.[doi:10.3969/j.issn.1006-1959.2020.01.050]
[5]陈 璐.温阳健脾汤治疗慢性萎缩性胃炎癌前病变的疗效及安全性[J].医学信息,2021,34(01):167.[doi:10.3969/j.issn.1006-1959.2021.01.046]
　CHEN Lu.Efficacy and Safety of Wenyang Jianpi Soup in the Treatment of CAG-PLGC[J].Journal of Medical Information,2021,34(12):167.[doi:10.3969/j.issn.1006-1959.2021.01.046]
[6]吴春凤,黄伟荣.黄伟荣从“虚”“瘀”论治慢性萎缩性胃炎[J].医学信息,2021,34(02):165.[doi:10.3969/j.issn.1006-1959.2021.02.046]
[7]吕学富.石斛养胃汤联合胶体果胶铋干混悬剂及阿莫西林治疗慢性萎缩性胃炎的临床疗效观察[J].医学信息,2021,34(24):163.[doi:10.3969/j.issn.1006-1959.2021.24.043]
　LYU Xue-fu.Clinical Efficacy of Shihu Yangwei Decoction Combined with Colloidal Bismuth Pectin for Suspension and Amoxicillin in the Treatment of Chronic Atrophic Gastritis[J].Journal of Medical Information,2021,34(12):163.[doi:10.3969/j.issn.1006-1959.2021.24.043]
[8]李虹霞,刘伏山.慢性萎缩性胃炎的中西医治疗[J].医学信息,2022,35(11):29.[doi:10.3969/j.issn.1006-1959.2022.11.009]
　LI Hong-Xia,LIU Fu-shan.Treatment of Chronic Atrophic Gastritis with Traditional Chinese and Western Medicine[J].Journal of Medical Information,2022,35(12):29.[doi:10.3969/j.issn.1006-1959.2022.11.009]
[9]熊 鹰.中医疗法在慢性萎缩性胃炎治疗中的研究现状[J].医学信息,2023,36(23):189.[doi:10.3969/j.issn.1006-1959.2023.23.047]
　XIONG Ying.Research Status of Traditional Chinese Medicine Therapy for Chronic Atrophic Gastritis[J].Journal of Medical Information,2023,36(12):189.[doi:10.3969/j.issn.1006-1959.2023.23.047]
[10]汪尚勇,姜立飞.双歧杆菌乳杆菌三联活菌联合改良序贯疗法治疗Hp阳性慢性萎缩性胃炎的疗效与安全性[J].医学信息,2023,36(24):69.[doi:10.3969/j.issn.1006-1959.2023.24.013]
　WANG Shang-yong,JIANG Li-fei.Efficacy and Safety of Live Combined Bifidobacterium and Lactobacillus Combined with Modified Sequential Therapy in the Treatment of Hp Positive Chronic Atrophic Gastritis[J].Journal of Medical Information,2023,36(12):69.[doi:10.3969/j.issn.1006-1959.2023.24.013]

更新日期/Last Update: 1900-01-01